Opioid Use and Pregnancy Outcomes in Women With a Hypertensive Disorder of Pregnancy [31C]
INTRODUCTION:Opioid use in pregnancy is increasing dramatically and is associated with poor maternal and neonatal outcomes. We sought to evaluate the relationship between opioid use and pregnancy outcomes among women with hypertensive disorders in pregnancy. METHODS:Retrospective cohort study among...
Saved in:
Published in | Obstetrics and gynecology (New York. 1953) Vol. 133 Suppl 1; no. 1; p. 39S |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved
01.05.2019
|
Online Access | Get full text |
Cover
Loading…
Summary: | INTRODUCTION:Opioid use in pregnancy is increasing dramatically and is associated with poor maternal and neonatal outcomes. We sought to evaluate the relationship between opioid use and pregnancy outcomes among women with hypertensive disorders in pregnancy.
METHODS:Retrospective cohort study among subjects with a hypertensive disorder of pregnancy that delivered ≥23 weeks gestation at a single institution (October ʼ13-April ʼ18). After IRB approval, subjects were stratified into two groups by opioid use (heroin, methadone or Subutex)current vs. non-users (never, quit prior to or during pregnancy). Differences were analyzed by Fisherʼs exact, t-test, and logistic regression, with α=0.05.
RESULTS:From 10,833 deliveries, 1,487 (13.7%) were classified with a hypertensive disorder of pregnancy. 41 subjects (2.8%) actively used opioids during pregnancy, 1,098 (73.8%) were non-users and 348 (23.4%) were excluded due to unknown opioid use. Subjects using opioids were more likely to be covered by public insurance and using other substances. There were no differences in final hypertensive diagnosis for opioid users vs. non-users (p=0.26), although opioid users more often had severe diastolic blood pressure (≥110 mmHg) compared to non-users (p=0.012). Opioid use was associated with both adverse maternal and neonatal outcomes, which remained significant after adjustment for maternal characteristics and other substance use (aOR2.99, p=0.033 and aOR3.13, p=0.009, respectively).
CONCLUSION:Among women with a hypertensive disorder of pregnancy, opioid use is associated with a 2-3 times increased odds for both adverse maternal and neonatal outcomes compared to non-users. These findings highlight the need to limit opioid use in pregnancy. |
---|---|
ISSN: | 0029-7844 1873-233X |
DOI: | 10.1097/01.AOG.0000559452.93150.e4 |